Related Experiment Videos

A propensity-matched study of hypertension and increased stroke-related hospitalization in chronic heart failure

Gerasimos S Filippatos1, Chris Adamopoulos, Xuemei Sui

  • 1University of Athens, Athens, Greece.

Insights

Patients with heart failure and a history of hypertension face a higher risk of stroke hospitalization. This study highlights the importance of managing hypertension in this vulnerable population to reduce stroke incidence.

Area of Science:

  • Cardiology
  • Neurology
  • Public Health

Background:

  • Hypertension is a known risk factor for cardiovascular events like heart failure and stroke.
  • The specific impact of hypertension on stroke risk in patients already diagnosed with heart failure remains under-researched.

Purpose of the Study:

  • To investigate the association between a history of hypertension and the risk of stroke hospitalization in patients with heart failure.

Main Methods:

  • Utilized data from the Digitalis Investigation Group trial, including 7,788 patients.
  • Employed propensity score matching to create balanced cohorts of patients with and without a history of hypertension.
  • Applied Kaplan-Meier and matched Cox regression analyses for outcome assessment over a median follow-up of 37 months.

Main Results:

  • A history of hypertension was significantly associated with an increased risk of hospitalization for stroke (Hazard Ratio=1.52; p=0.010).
  • This increased risk persisted even in patients with well-controlled baseline systolic blood pressure (<140 mm Hg).
  • Matched patients with and without hypertension history had similar mean systolic blood pressure (127 mm Hg) post-matching.

Conclusions:

  • A history of hypertension independently increases the risk of stroke hospitalization in heart failure patients.
  • Effective hypertension management is crucial for mitigating stroke risk in individuals with heart failure.
  • Further research should explore optimal blood pressure targets in this patient group.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...